Considering the uALCAM in LN patients is significantly greater than 1 ng/ml, the positive control samples was 1.5 ng/ml ALCAM spiked in running buffer-A, which is three times the limit of detection of ALCAM. This evidence concerns the gene ALCAM and lobular neoplasia.